The average one-year price target for Fennec Pharmaceuticals (TSX:FRX) has been revised to $21.57 / share. This is an increase of 10.41% from the prior estimate of $19.53 dated November 16, 2025. The ...
) has been revised to $18.36 / share. This is an increase of 200.00% from the prior estimate of $6.12 dated December 18, 2025. The price target is an average of many targets provided by analysts. The ...
Read award-winning journalism from the best writers in racing, with exclusive news, interviews, columns, investigations, stable tours and subscriber-only emails.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results